Neuberger Berman Group’s CareDx CDNA Stock Holding History

Neuberger Berman Group’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-59,225	Closed	-$2.19M	–	1863
2022 Q1	$2.19M	Buy	59,225 +587	+1%	+$22.9K	﹤0.01%	1150
2021 Q4	$2.63M	Sell	58,638 -35,439	-38%	-$1.85M	﹤0.01%	1128
2021 Q3	$5.96M	Buy	94,077 +580	+0.6%	+$44.2K	0.01%	915
2021 Q2	$8.55M	Buy	93,497 +32,225	+53%	+$2.56M	0.01%	852
2021 Q1	$4.17M	Buy	61,272 +51,272	+513%	+$3.98M	﹤0.01%	994
2020 Q4	$725K	Hold	10,000	–	–	﹤0.01%	1327
2020 Q3	$379K	Hold	10,000	–	–	﹤0.01%	1394
2020 Q2	$354K	Sell	10,000 -428,405	-98%	-$12.2M	﹤0.01%	1344
2020 Q1	$9.57M	Buy	438,405 +428,403	+4,283%	+$9.6M	0.01%	675
2019 Q4	$216K	Buy	+10,002	New	+$229K	﹤0.01%	1457
2019 Q1	–	Sell	-24,000	Closed	-$603K	–	1528
2018 Q4	$603K	Buy	+24,000	New	+$617K	﹤0.01%	1213

Other funds holding CDNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Neuberger Berman Group's CDNA Position: Q2 2022 in Review

Neuberger Berman Group sold out of CareDx (CDNA) in Q2 2022, closing a stake of 59,225 shares — an estimated $2.19M sold.

Neuberger Berman Group first reported a position in CDNA in Q4 2018 and held it in 11 quarters. The position peaked at $9.57M in Q1 2020. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.

Neuberger Berman Group reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
Neuberger Berman Group sold 59,225 CareDx shares in Q2 2022, an estimated $2.19M.
Neuberger Berman Group first reported a position in CareDx in Q4 2018 and held it in 11 quarters.
Neuberger Berman Group's CareDx position peaked at $9.57M in Q1 2020.
184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.

Based on Neuberger Berman Group's 13F filing for Q2 2022, filed 15 Aug 2022.